European Archives - Page 939 of 1021 - European Medical Journal

EMJ

European Liver Patients’ Association (ELPA) Launches Call to Action Report for the Treatment of Hepatic Encephalopathy

BRUSSELS, BELGIUM, 12 October 2015, 18:30 CET – ELPA today launched a new call to action report ‘Time to DeLiver: Getting a Grip on HE’ at the…

EMJ

Exercise and Stop Smoking to Improve Depression after Heart Attack

Sophia Antipolis, 10 October 2015: Exercise and stop smoking to improve depression after a heart attack, the European Society of Cardiology (ESC) urged …

EMJ

Heartening Protein Patch Developed to Repair Cardiomyocyte Damage

A REVOLUTIONARY ‘protein patch’ has been developed that repairs the damage caused by a heart attack. Investigating a treatment to address the inability…

EMJ

Catheter Ablation Versus Drug Therapy: The Atrial Fibrillation Showdown

EVIDENCE that catheter ablation is superior to drug therapy for reducing atrial fibrillation (AF) has been newly presented. A recent trial investigating…

EMJ

TMIGD1: A Protein; an Immunoglobulin; a Protector of Kidney Cells

TRANSMEMBRANE and immunoglobulin domain-containing 1 (TMIGD1), a previously unknown protein involved in protecting kidney epithelial cells…

EMJ

Cool Organ Donors May Improve Kidney Transplantation

COOLING the body of a deceased organ donor by 2°C less than normal body temperature could increase the efficiency of kidney transplantation…

EMJ

Norgine Completes Agreement With Aspen For Its Southern African Operations And Product Rights

London. 30 September 2015, 14:00 BST. Norgine B.V. today announced that it has completed its agreement with Pharmacare Limited, a wholly owned subsidiary…

EMJ

Astellas European Foundation Grant Awarded to Look at Novel Molecular Imaging Techniques to Support Patients with Prostate Cancer

Chertsey, England [28th September, 2015] The 2015 Astellas European Foundation Uro‐Oncology Grant was awarded last night to a team led by…

EMJ

Large TAILORx Outcomes Study Demonstrates 99% of Patients with Low Oncotype DX® Recurrence Score® Results Were Breast Cancer Relapse-Free following Five Years of Hormone Therapy Alone

GENEVA, Switzerland, [September 28, 2015] – Genomic Health today announced the presentation of the first results1 from the Trial Assigning…

EMJ

Fractyl Announces Positive Results from 39-Patient Study of Revita DMR System

LONDON, UK AND WALTHAM, MA. – September 28, 2015 – Fractyl Laboratories, Inc. (Fractyl) today announced results from a 39-patient, single-site…